6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
3h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
4h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
6h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
14h ago	Buffalo Potash Files Annual Information Form and New Technical Report
15h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

1.30ILA-0.10 -7.14%

Closed • Updated at 17:52 GMT+00:00

Market Cap$11.73M

Volume7.40M

Beta0.36

RSI42.98

Gross Margin35.62%

Health TechnologyPharmaceuticals: Major

Biolinerx Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma

BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

BioLineRx Reports 2025 Financial Results and Provides Corporate Update

BioLineRx to Report 2025 Annual Results on March 23, 2026

Community Chat

Ask AI